These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32696593)

  • 1. Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Itoh Y; Hanafusa T
    J Diabetes Investig; 2021 Apr; 12(4):510-515. PubMed ID: 32696593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Individual Positive Anti-Islet Autoantibodies from 3 Screen ICA Titer.
    Kawasaki E; Jinnouchi H; Maeda Y; Okada A; Kawai K
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans.
    Gomes KF; Semzezem C; Batista R; Fukui RT; Santos AS; Correia MR; Passos-Bueno MR; Silva ME
    Sci Rep; 2017 Mar; 7(1):207. PubMed ID: 28303020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays.
    Lind A; Freyhult E; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Larsson HE; Lundgren M; Carlsson A; Nilsson AL; Fex M; Törn C; Agardh D; Tsai CT; Lernmark Å;
    EBioMedicine; 2024 Jun; 104():105144. PubMed ID: 38723553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.
    Asanghanwa M; Gorus FK; Weets I; der Auwera BV; Aminkeng F; Mbunwe E; Goubert P; Verhaeghen K; Sobngwi E; Wenzlau JM; Hutton JC; Pipeleers DG; Keymeulen B; Mbanya JC; van Schravendijk C
    Diabetes Res Clin Pract; 2014 Jan; 103(1):97-105. PubMed ID: 24332797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes.
    Elmaoğulları S; Uçaktürk SA; Elbeg Ş; Döğer E; Tayfun M; Gürbüz F; Bideci A
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):108-112. PubMed ID: 28943512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
    Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
    Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of islet autoantibodies in Thai juvenile-onset type 1 diabetes.
    Trisorus C; Aroonparkmongkol S; Kongmanas HB; Sahakitrungruang T
    Pediatr Int; 2018 Nov; 60(11):1002-1007. PubMed ID: 30151912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.
    De Grijse J; Asanghanwa M; Nouthe B; Albrecher N; Goubert P; Vermeulen I; Van Der Meeren S; Decochez K; Weets I; Keymeulen B; Lampasona V; Wenzlau J; Hutton JC; Pipeleers D; Gorus FK;
    Diabetologia; 2010 Mar; 53(3):517-24. PubMed ID: 20091020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort.
    Garnier L; Marchand L; Benoit M; Nicolino M; Bendelac N; Wright C; Moulin P; Lombard C; Thivolet C; Fabien N
    Clin Chim Acta; 2018 Mar; 478():162-165. PubMed ID: 29288641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes.
    Sørgjerd EP
    Curr Diabetes Rev; 2019; 15(3):199-204. PubMed ID: 30058495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.